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This study was conducted to elucidate the in vitro protective effect of five flavonoids [apigenin (1), apigenin-7-O-glucoside 
(2), centaureidin (3), jaceidin (4) and quercetin (5)] against chromosomal damage in mitogen-induced human lymphocytes. 
Using the Cytochalasin-B blocked micronucleus (CBMN) assay, in which the biomarker of chromosome breakage and/or 
chromosome loss is the elevated frequency of micronucleus (MN) in binucleated (BN) cells, the presence of flavonoid 2 in 
minimal concentration (3 µg/mL) gave a 35.5% decrease in the frequency of MN when compared with control human 
lymphocytes. The same concentration of flavonoids 1, 3 and 4, reduced the MN frequency by 24.4%, 28.0% and 28.0%, 
respectively. Higher concentrations (6 µg/mL and 10 µg/mL) seemed less effective. Flavonoid 5 (3 µg/mL) induced a slight 
decrease in MN frequency (5%), while higher doses (6 µg/mL and 10 µg/mL) provoked an increase of DNA damage. The 
comparable values for the cytokinesis-block proliferation index (CBPI) of the tested flavonoids and positive control suggested 
an inhibitory effect on lymphocyte proliferation. In the DPPH· scavenging assay, flavonoids 1-4 demonstrated modest activity, 
in a dose-dependent manner, compared with the synthetic antioxidants BHT and Trolox, while 5 exhibited comparably high 
antioxidative activity. 
 




Flavonoids are phenolic substances isolated from a wide 
range of vascular plants, with over 8000 individual 
compounds known. Many studies suggest that 
flavonoids exhibit biological activities, including 
antiallergenic, antiviral, antiinflammatory and 
vasodilatory. Most interest has been devoted to the 
antioxidant activity of flavonoids, due to their ability to 
reduce free radical formation and to scavenge free 
radicals [1a,1b]. 
 
Increased DNA damage is associated with illness such 
as Alzheimer's and Parkinson's disease. Micronuclei 
(MNs), which are biomarkers of chromosome breakage 
and/or whole chromosome loss, were significantly 
higher within peripheral blood lymphocytes of 
Alzheimer's [1c] and Parkinson's [1d] patients. Werner 
syndrome, often followed by osteoporosis, 
arteriosclerosis, diabetes and cancer is associated with 
increase of MNs in fibroblasts culture [1e]. The extent 
of DNA damage is successfully measured using the 
cytokinesis-block micronucleus (CBMN) assay. 
Micronuclei are efficiently expressed in dividing cells 
when chromosome breaks are induced by hydroxyl 
radicals [1f]. The CBMN technique enables micronuclei 
to be specifically scored in cells that have completed 
nuclear division and is, therefore, not influenced by 
variations in cell division kinetics [1g]. Currently, the 
CBMN assay is being used extensively to evaluate the 
presence and extent of chromosome damage (both 
clastogenic and aneuploid) in human populations that 
are exposed to genotoxic agents in different 
occupational settings, environments and lifestyles. 
 
We employed the CBMN assay in normal human 
peripheral lymphocytes to evaluate the ability of 
apigenin (1), apigenin-7-O-glucoside (2), centaureidin 
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(3) and jaceidin (4), isolated from two Achillea species 
[2a,2b], along with commercially available quercetin 
(5), to protect human lymphocyte cells against 
chromosomal damage. The results were compared with 
a positive control (Amifostine) and control cell culture. 
Flavonoids 1-5 were also subjected to the DPPH• 
scavenging assay and the results compared with the 
literature data for the synthetic antioxidants BHT and 
Trolox. In this study we found the lowest concentration 
(3 µg/mL) at which each of the tested flavonoids 
exerted a beneficial effect on control lymphocyte cells 
by decreasing the frequency of MN in comparison with 
the positive control, Amifostin WR 2721 (A-WR). 
Among the tested flavonoids, apigenin-7-O-glucoside 
(2) exibited the most prominent effect, decreasing the 
frequency of MN by 35.5%. The reductions of the MN 
frequency for flavonoids 1, 3 and 4 were 24.4%, 28.0% 
and 28.0%, respectively, when compared with control 
cell cultures (calculated from Table 1).  
 
The cell culture treated with amifostin WR-2721 
(positive control) at a concentration of 1 µg/mL gave a 
decrease in the frequency of MN by 19.5% when 
compared with the control cell culture. Treatment of the 
cell culture with quercetin (5) at concentration of 3 
µg/mL produced a decrease in the frequency of MN by 
5.5% compared with control human lymphocytes, while 
6 µg/mL and 10 µg/mL increased the MN frequency by 
11% and 72%, respectively, compared with control 
human lymphocytes (Table 1). 
 
Higher concentrations (6 and 10 μg/mL) of flavonoids 
1-4 were less effective, compared with control human 
cells (Table 1). The reduction of the MN frequency for 
flavonoids 1, 3 and 4 were 18.7%, 12.0%, and 16.3%, 
when 6 μg/mL were applied, and 4%, 4%, and 0.6%, for 
10 μg/mL concentrations. Apigenin-7-O-glucoside (2), 
at concentrations of 6 and 10 µg/mL, decreased the MN 
frequency by 24.3% and 9.1%, respectively, compared 
with control human lymphocytes (Table 1). The number 
of micronuclei (MN) scored per 1000 binuclear (BN) 
cells increased in a dose dependant manner in 
experiments with 6 μg/mL and 10 μg/mL of flavonoids 
1-4 (Table 2). These results are in accordance with a 
previous study of apigenin (1) in which lower doses 
(2,5-10 µg/mL) decreased the frequency of MN and 
thus protected human lymphocytes if added to cell 
cultures, while higher doses (25 µg/mL) increased the 
MN frequency exerting a possible toxic effect [2c]. 
 
The effect of flavonoids 1-5 on cell proliferation was 
investigated by determining the cytokinesis-block 
proliferation index (CBPI). Table 1 shows the mean 
CBPI values and the standard errors calculated for 
different concentrations of flavonoids. No significant 
difference in CBPI was observed between different 
concentrations  of  apigenin,  apigenin-7-O-glucoside,  
Table 1: Cytokinesis-block proliferation index (CBPI) and micronuclei 
(MN) per 1000 binucleated (BN) cells for three different concentrations 
of flavonoids (1-5). 
 
compd  Conc. CBPI MN  
  (µg/mL)  (Mean ± S.E.) 
control 0 1.68 ± 0.05 25.43 ± 3.0 
positive control 1 1.62 ± 0.01  20.46 ± 0.55 
 3 1.59 ± 0.02  19.21 ± 0.52 
1 6 1.63 ± 0.03 20.67 ± 1.73 
 10 1.66 ± 0.01 24.42 ± 0.22  b 
 3 1.58 ± 0.01 16.31  ±  0.86 a; b 
2 6 1.64 ± 0.01 19.23 ± 1.34 
 10 1.66 ± 0.02 23.12 ± 0.88 b 
 3 1.59 ± 0.03 18.03 ± 2.07 
3 6 1.65 ± 0.03 22.37 ± 0.70 
 10 1.68 ± 0.05 24.41 ± 0.43 b 
 3 1.60 ± 0.01 18.31 ± 0.83 
4 6 1.66 ± 0.03 21.28 ± 0.54 
  10 1.68 ± 0.02 25.27 ± 0.35 b 
 3 1.71 ± 0.01 24.04 ± 2.04 
5 6 1.70 ± 0.02 28.06 ± 2.63  b* 
  10 1.64 ± 0.02 43.82 ± 2.36 a *; b 
The statistical significance of difference between the data pairs was evaluated 
by analysis of variance (one-way ANOVA) followed by the Tukey test. 
Difference was considered significant at p < 0.05. 
a →  compared with control groups, statistically significant difference p<0.05; 
a∗ → compared with control groups, statistically significant difference p<0.01; 
b→ compared with amifostine – WR 2721, statistically significant difference 




Figure 1: Cytokinesis-block proliferation index (CBPI) in cultured human 
lymphocytes: control (1); positive control amifostine WR-2721 (2). Flavonoids in 
concentrations of 3 µg/mL, 6 µg/mL and 10 µg/mL: apigenin (3-5); apigenin-7-O-
glucoside (6-8); centaureidin (9-11); jaceidin (12-14); quercetin (15-17). 
 
centaureidin, jaceidin and quercetin  (Figure 1). A 
similar conclusion had been drawn for three larger 
concentrations of apigenin (10 μM, 33 μM and 100 μM) 
[2d]. The comparable CBPI values for the compounds 
and positive control suggested an inhibitory effect on 
lymphocyte proliferation of the tested flavonoids. 
Furthermore, no signs of cytotoxicity of the flavonoids 
at the doses used in this study could be observed after 
trypan blue staining. 
 
In this study we found that a protective effect against 
chromosomal damage in the CBMN assay was achieved 
with the lowest concentration used (3 μg/mL) of the 
tested flavonoids 1-4, while higher concentrations        
(6 μg/mL and 10 μg/mL) were less effective. Since the 
number of micronuclei serves as an indicator of DNA 
damage,  these results indicate that flavonoids isolated 
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Table 2: Distribution of micronuclei (MN) in binucleated (BN) human 
lymphocytes for three different concentrations of flavonoids (1-5). 
 
 compd conc. D I S T R I B U T I O N  
  (µg/mL) 0 1 2 3 4 
control 0 4079 81 11 1 0 
Positive control 1 4031 67 7 1 0 
 3 4043 60 8 1 0 
1 6 4045 56 9 1 2 
 10 4066 51 13 4 3 
 3 4030 46 9 1 0 
2 6 4045 60 13 1 0 
 10 4032 63 10 4 0 
 3 4037 58 8 0 0 
3 6 4055 58 11 2 1 
 10 4054 70 9 3 1 
 3 4028 61 5 0 1 
4 6 4053 70 9 0 0 
  10 4034 63 12 3 2 
 3 4031 75 6 4 0 
5 6 4099 81 12 3 1 
  10 4090 159 14 0 0 
 
from extracts of Achillea species, especially apigenin-7-
O-glucoside, protected DNA in human lymphocytes. 
We observed that quercetin (5) exerted an opposite 
effect, inducing an increase of DNA damage at higher 
concentration. It has already been shown that quercetin 
induces chromosomal damage in the CBMN assay using 
a lymphoblastoid cell line [3a]. In previous studies, the 
CBMN assay using a lymphoblastoid cell line has been 
established as an effective system to detect ROS-
induced chromosomal damage [3b]. 
 
The ability of flavonoids 1-5 to scavenge the DPPH 
radical was tested, and the concentrations of the 
flavonoids varied between 0.25-5.5 mM. The 
scavenging effect of 1-4 on the DPPH radical increased 
linearly with concentration, reaching EC50 values at 
1.88 ± 0.02 mM, 4.69 ± 0.03 mM, 2.17 ± 0.02 mM    
and 1.13 ± 0.01 mM, respectively. Quercetin (5) 
demonstrated a strong scavenging effect with an EC50 
value of 0.012 ± 0.001 mM. These values were also 
compared with literature data for the synthetic 
antioxidants BHT (0.028 ± 0.001 mM) and Trolox 
(0.027 ± 0.001mM) [3c]. The strong scavenging effect 
of 5 is probably due to the presence of 3'-OH attached to 
the 2',3'-double bond with a carbonyl in the 4' position, 
as well as the 4,5-diphenolic structure of ring B [3d]. If 
the hydroxy groups at positions 3',4,5- were either 
blocked or not present in the molecule, the scavenging 
activity would be weakened, as in the case of flavonoids 
1-4. 
 
Flavonoids 1-4 isolated from Achillea species showed a 
protective effect against chromosomal damage in the 
CBMN assay in diverse proportion to the tested 
concentrations, while their mild DPPH• scavenging 
capacity was directly proportional to the tested 
concentrations. Strong DPPH• scavenging capacity was 
observed for 5, while higher concentrations induced an 
increase of DNA damage in the CBMN assay. No signs 
of cytotoxicity of flavonoids 1-5 at the doses used in 
this study could be observed, but an inhibitory effect on 
lymphocyte proliferation was noticed. The present 
results demonstrate that flavonoids 1-4 could have 




Subjects: Venus blood samples were withdrawn into 
sterile heparinized vacutainer tubes (Becton Dickinson, 
Bradford, MA) from 6 healthy, non-smoking, male 
volunteers who had not been exposed to chemicals, 
drugs or other substances. A safety protocol concerning 
blood-born pathogen/biohazard was applied. The 
volunteers gave their permission for using their blood 
for the experiment. From each subject, 2 aliquots of 
blood, each of 5 mL, were obtained. The study 
complied with the code of ethics of the World Medical 
Association (Helsinki Declaration of 1964, as revised in 
2002). The blood samples were obtained at the Medical 
Unit in accordance with current Health and Ethical 
regulations in Serbia (Law on Health Care, 2005). 
 
Cytokinesis-block micronucleus (CBMN) assay: The 
culture lymphocytes were treated with flavonoids 1-4, 
isolated and purified, as described [2a,2b], and 
purchased quercetin (5) (Sigma-Aldrich, Vienna, 
Austria). Three concentrations of flavonoids were used, 
i.e. 3 µg/mL, 6 µg/mL and 10 µg/mL. One cell culture 
served as the control and, to this, flavonoid was          
not added. Amifostine WR- 2721 (S-2[3-
aminopropylamino]-ethylphosphothioic acid; Marligen-
Biosciences, USA) was added to one culture tube at a 
concentration of 1 μg/mL; this served as a positive 
control. All cultures were incubated at 37ºC. Treatment 
with flavonoids 1-5 lasted for 19 h, because it has been 
calculated that this is the time duration necessary for the 
flavonoids ingested by the organism per se to be 
metabolised and excreted. Consequently, all cultures 
were rinsed with pure medium, transferred into 5 mL 
fresh RPMI 1640 medium (RPMI 1640 Medium + 
GlutaMAX + 25mM HEPES; Invitrogen- Gibco-BRL, 
Vienna, Austria) and incubated for an additional 72 h. 
 
The CBMN test was performed according to a described 
procedure [1f]. Lymphocytes were stimulated with 2.4 
µg/mL of phytohemaglutinin (Invitrogen- Gibco-BRL, 
Vienna, Austria). Briefly, 44 h affter culture initiation, 
Cytochalasin B (Cyt-B; Invitrogen-Gibco-BRL, Vienna, 
Austria) was added to each culture tube, resulting in a 
final concentration of 6 μg/mL. Cells were harvested   
28 h  after the addition of Cyt-B. The total culture    
time was 72 h. This resulted in the formation of many 
first division binucleated cells that were scored for     
the induction of MN. After incubation for 72 h, the 
cultures were harvested and fixed in 3 changes of 
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methanol/acetic acid (3:1 v/v). The cells were spread 
onto glass slides (2 slides for each culture), dried and 
stained with alkaline Giemsa (Sigma-Aldrich, Vienna, 
Austria). Experiments were repeated on the samples of 
blood obtained from each donor and the results were 
summarized. MN were scored in 1000 binucleated cells 
per slide, registering MN according to established 
criteria [3e] 
 
The effects of flavonoids 1-5 on cell proliferation were 
determining from the cytokinesis-block proliferation 
index (CBPI). The CBPI was calculated as suggested by 
Surralles [3f], i.e. CBPI = [(MI +2MII + 3(MIII + MIV)] 
/ N, where MI-MIV represents the number of cells with 
1-4 nuclei, and N is the number of cells scored. For the 
analysis of MN, only binucleated cells with well-
preserved cytoplasm were scored for MN (under a light 
microscope with a 40 x 10 magnification). The criteria 
for selection of binucleated cells and identification of 
MN given in the HUMAN project website 
[http://www.humn.org] were followed. The numbers of 
binucleated cells with 1, 2, 3 and more MN were then 
tabulated. The data for each treatment were expressed as 
the frequency of MN per 1000 binucleated cells.  
 
DPPH• scavenging assay: Flavonoids 1-5 were 
subjected to the DPPH• scavenging assay according to 
the described procedure [3g]. The samples were 
prepared by addition of various concentrations of 
flavonoid in MeOH (300 µL) to 0.1 mg/mL methanolic 
solution of DPPH (300 µL). Absorbance at 517 nm was 
measured after 30 min. The inhibition percentage was 
calculated using the following equation: 
 
100]/)[( xAcAsAcI −=  
 
where I is the inhibition percentage, Ac is the 
absorbance of the negative control (flavonoid was 
omitted in the sample), and As is the absorbance of the 
sample. Trolox and tert-butyl hydroxytoluene (BHT) 
were used as positive controls [3c]. The inhibition 
percentage was plotted against concentration of the 
samples, and EC50 values were determined by linear 
regression analysis. The results are expressed as means 
± standard deviation of three determinations. 
 
Statistical analysis: The statistical analysis was 
performed using Origin software package version 7.0. 
The statistical significance of difference between the 
data pairs was evaluated by analysis of variance (one-
way ANOVA), followed by the Tukey test. Statistical 
difference was considered significant at p < 0.05. The 
index calculating is presented as the % of change 
comparing different groups. 
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